Balance Sheet Data

Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

$6.7
0.33 (+5.18%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Total Cash 273.93307.62353.30158.54307.07445.55125.84125.88122.04118.31114.70111.20
Total Cash (%)
Account Receivables 30.7832.2131.4752.2481.4023.4322.0817.0316.5116.0015.5215.04
Account Receivables (%)
Inventories 26.1726.8436.4843.1337.5029.0125.2214.8714.4213.9813.5513.14
Inventories (%)
Accounts Payable 17.9820.2917.0729.9131.0749.3726.8413.1412.7412.3511.9811.61
Accounts Payable (%)
Capital Expenditure -14.66-483.93-7.07-273.54-14.38-33.91-90.43-62.78-60.87-59.01-57.21-55.46
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.